If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
6th Feb 20205:50 pmRNSNet Asset Value(s) - Weekly Estimate
6th Feb 20204:37 pmRNSNet Asset Value(s) Month End Final
31st Jan 20207:00 amRNSNotice of EGM
30th Jan 202010:57 amRNSNet Asset Value(s) - Weekly Estimate
23rd Jan 20204:51 pmRNSNet Asset Value(s) - Weekly Estimate
20th Jan 20204:53 pmRNSHolding(s) in Company
17th Jan 20209:28 amRNSNet Asset Value(s) - Weekly Estimate
10th Jan 20204:32 pmRNSCash Exit Payment
8th Jan 20204:53 pmRNSNet Asset Value(s) - Monthly Estimate
2nd Jan 20204:33 pmRNSNet Asset Value(s) - Weekly Estimate
31st Dec 201911:49 amRNS2019 Redemption Portfolio
30th Dec 20194:09 pmRNSNet Asset Value(s) - Weekly Estimate
30th Dec 201912:01 pmRNSNet Asset Value(s) - Month End Final
30th Dec 201910:30 amRNSHolding(s) in Company
23rd Dec 20191:06 pmRNSDirector/PDMR Shareholding
19th Dec 201911:51 amRNS2019 Redemption Portfolio
18th Dec 20195:23 pmRNSNet Asset Value(s) - Weekly Estimate
11th Dec 20195:13 pmRNSNet Asset Value(s)- Weekly Estimate
4th Dec 20194:59 pmRNSNet Asset Value(s) - Weekly Estimate
2nd Dec 20194:56 pmRNSNet Asset Value(s) - Weekly Estimate
29th Nov 20193:25 pmRNSNet Asset Value(s) - Month End Final
21st Nov 20193:11 pmRNSNet Asset Value(s) - Weekly Estimate
21st Nov 201910:54 amRNSHolding(s) in Company
18th Nov 201912:55 pmRNSDirector/PDMR Shareholding
13th Nov 20191:21 pmRNSNet Asset Value(s) - Weekly Estimate
12th Nov 20193:17 pmRNSChange of Adviser
12th Nov 20197:00 amRNSNet Asset Value(s) - Weekly Estimate
11th Nov 20197:00 amRNSNet Asset Value(s) - Monthly Estimate
30th Oct 20193:06 pmRNSNet Asset Value(s) - Weekly Estimate
30th Oct 20198:00 amRNSDirector Declaration
29th Oct 20199:47 amRNSHolding(s) in Company
28th Oct 201911:50 amRNSNet Asset Value(s) - Weekly Estimate
28th Oct 20199:34 amRNSUpdate from Manager
25th Oct 20193:11 pmRNSHolding(s) in Company
18th Oct 20194:21 pmRNSNet Asset Value(s) - Weekly Estimate
15th Oct 20199:14 amRNSCash Exit Payments
14th Oct 201910:19 amRNSDirectorate Change
9th Oct 20193:35 pmRNSHCC Proceeds and Weekly Estimated NAV
4th Oct 20193:53 pmRNSNet Asset Value(s) Month End Final
3rd Oct 20198:28 amRNSHolding(s) in Company
1st Oct 20198:00 amRNSTotal Voting Rights
27th Sep 20195:21 pmRNSNet Asset Value(s)- Weekly Estimate
26th Sep 201910:15 amRNSCorrection to Total Voting Rights
26th Sep 20199:24 amRNSHolding(s) in Company
25th Sep 201910:04 amRNSHolding(s) in Company
24th Sep 201911:58 amRNSHolding(s) in Company (replacement)
23rd Sep 20193:41 pmRNSHolding(s) in Company
19th Sep 20195:08 pmRNSHolding(s) in Company
19th Sep 20194:39 pmRNSHolding(s) in Company
18th Sep 20193:14 pmRNSChange of Name, TIDM, and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.